Study Name: Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis
14 locations found
- Novartis Investigative Site
Location: Mesa, Arizona 85202
- Novartis Investigative Site
Location: Paradise Valley, Arizona 85253
- Novartis Investigative Site
Location: Phoenix, Arizona 85037
- Novartis Investigative Site
Location: Fort Lauderdale, Florida 33321
- Novartis Investigative Site
Location: Newnan, Georgia 30263
- Novartis Investigative Site
Location: Eagan, Minnesota 55121
- Novartis Investigative Site
Location: Freehold, New Jersey 07728
- Novartis Investigative Site
Location: Charlotte, North Carolina 28210
- Novartis Investigative Site
Location: Johnston, Rhode Island 02919
- Novartis Investigative Site
Location: Columbia, South Carolina 29204
- Novartis Investigative Site
Location: North Charleston, South Carolina 29406
- Novartis Investigative Site
Location: Dallas, Texas 75216
- Novartis Investigative Site
Location: Houston, Texas 77074
- Novartis Investigative Site
Location: Mesquite, Texas 75150
|